PRE-MARKET INDIAN STOCKS NEWS: Infosys (INFO IS) Q1 (INR) net rose 12% Y/Y to 77.69bln, rev. rose 14% Y/Y to 482.11bln
Indian markets saw mixed Q1 results: Infosys trimmed revenue guidance, pharmaceutical firms faced API hurdles, and IndiGo reported a surprise loss despite strong revenue growth.
News detail
Cipla (CIPLA IS) - Co. Q1 (INR) net fell 39% Y/Y to 7.89bln. (ET)Dr Reddy’s Laboratories (DRRD IS) - Co. expects to resume supplies of generic semaglutide by November after resolving API quality issues that forced it to halt shipments. (ET)IndiGo (INDIGO IS) - Co. Q1 (INR) net loss 2.38bln (prev. profit 21.76bln Y/Y), rev. rose 20% Y/Y to 245.84bln. (ET)Infosys (INFO IS) - Co. Q1 (INR) net rose 12% Y/Y to 77.69bln, rev. rose 14% Y/Y to 482.11bln. (ET)Suzlon Energy (SUEL IS) - Co. secured a 201.6MW wind-energy project order in Andhra Pradesh from Waaree Forever Energies. (ET)Wipro (WPRO IS) - Co.’s Consumer Care & Lighting unit will acquire TTK Healthcare’s Good Home and Eva brands for INR 2.56bln, expanding its home-care and personal-care portfolio. (ET)
What do investors think?
StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.